To unravel the antitumor mechanism of combining RT with the CSF1R inhibitor, flow cytometry analysis was conducted on immune cell subsets within the subcutaneous tumor tissues of Lewis lung carcinoma and SCC7 head and neck squamous cell carcinoma models. Here, CSF1R is linked to neoplasm.